The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
MHC Class I Deficiency: Susceptibility to Natural Killer (NK) Cells and Impaired NK Activity
Abstract
The role of major histocompatibility complex (MHC) class I expression in natural killer (NK) cell target recognition is controversial. Normal T cell blasts from MHC class I-deficient mutant mice were found to serve as target cells for NK cells in vitro, which suggests that MHC class I molecules are directly involved in NK cell recognition. Spleen cells from the mutant mice were deficient in their ability to lyse MHC class I-deficient target cells or NK-susceptible tumor targets, and mutant mice could not reject allogeneic bone marrow. Thus, class I molecules may participate in the positive selection or tolerance induction of NK cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
Kärre, K., Ljunggren, H. G., Piontek, G., & Kiessling, R. (1986) · Nature · doi:10.1038/319675a0 · Cited by 2,161
Jonjić, S., Mutter, W., Weiland, F., Reddehase, M. J., & Koszinowski, U. H. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.4.1199 · Cited by 2,105
β2-Microglobulin deficient mice lack CD4−8+ cytolytic T cells
Zijlstra, M., Bix, M., Simister, N. E., Loring, J. M., Raulet, D. H., & Jaenisch, R. (1990) · Nature · doi:10.1038/344742a0 · Cited by 1,012
Self-citationNormal Development of Mice Deficient in β 2 M, MCClass I Proteins, and CD8 + T Cells
Koller, B. H., Marrack, P., Kappler, J. W., & Smithies, O. (1990) · Science · doi:10.1126/science.2112266 · Cited by 881
Characterization of a monoclonal antibody which detects all murine alpha beta T cell receptors.
Kubo, R. T., Born, W., Kappler, J. W., Marrack, P., & Pigeon, M. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.8.2736 · Cited by 747
Enhanced NK cell activity in mice injected with interferon and interferon inducers
GIDLUND, M., ÖRN, A., WIGZELL, H., SENIK, A., & GRESSER, I. (1978) · Nature · doi:10.1038/273759a0 · Cited by 734
Augmentation of Mouse Natural Killer Cell Activity by Interferon and Interferon Inducers
Djeu, J. Y., Heinbaugh, J. A., Holden, H. T., & Herberman, R. B. (1979) · The Journal of Immunology · doi:10.4049/jimmunol.122.1.175 · Cited by 602
Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency
Schuler, W., Weiler, I. J., Schuler, A., Phillips, R. A., Rosenberg, N., Mak, T. W., Kearney, J. F., Perry, R. P., & Bosma, M. J. (1986) · Cell · doi:10.1016/0092-8674(86)90695-1 · Cited by 545
Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice
Bix, M., Liao, N.-S., Zijlstra, M., Loring, J., Jaenisch, R., & Raulet, D. (1991) · Nature · doi:10.1038/349329a0 · Cited by 431
Self-citationEstablishment of Monoclonal Anti-Nk-1.1 Antibody
KOO, G. C., & PEPPARD, J. R. (1984) · Hybridoma · doi:10.1089/hyb.1984.3.301 · Cited by 347
Cited by
Innate or adaptive immunity? The example of natural killer cells
Vivier, E., Raulet, D. H., Moretta, A., Caligiuri, M. A., Zitvogel, L., Lanier, L. L., Yokoyama, W. M., & Ugolini, S. (2011) · Science · doi:10.1126/science.1198687 · Cited by 2,824
Self-citationRoles of the immune system in cancer: From tumor initiation to metastatic progression
Gonzalez, H., Hagerling, C., & Werb, Z. (2018) · Genes & Development · doi:10.1101/gad.314617.118 · Cited by 2,111
Lanier, L. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.359 · Cited by 1,648
Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition
Long, E. O., Sik Kim, H., Liu, D., Peterson, M. E., & Rajagopalan, S. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075005 · Cited by 1,217
Commitment to the B-lymphoid lineage depends on the transcription factor Pax5
Nutt, S. L., Heavey, B., Rolink, A. G., & Busslinger, M. (1999) · Nature · doi:10.1038/44076 · Cited by 1,179
Lam, K.-P., Kühn, R., & Rajewsky, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80373-6 · Cited by 1,108
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
Diefenbach, A., Jensen, E. R., Jamieson, A. M., & Raulet, D. H. (2001) · Nature · doi:10.1038/35093109 · Cited by 1,083
“1 p or CD8 p T cells were depleted before the cytotoxicity assay by complement (C′)-mediated lysis as describe”
MethodSelf-citationRECEPTORS FOR HLA CLASS-I MOLECULES IN HUMAN NATURAL KILLER CELLS
Moretta, A., Bottino, C., Vitale, M., Pende, D., Biassoni, R., Mingari, M. C., & Moretta, L. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.619 · Cited by 875
Targeting natural killer cells and natural killer T cells in cancer
Vivier, E., Ugolini, S., Blaise, D., Chabannon, C., & Brossay, L. (2012) · Nature Reviews Immunology · doi:10.1038/nri3174 · Cited by 850
The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy
Paul, S., & Lal, G. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01124 · Cited by 825
MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells
Karlhofer, F. M., Ribaudo, R. K., & Yokoyama, W. M. (1992) · Nature · doi:10.1038/358066a0 · Cited by 797
Flynn, J. L., Goldstein, M. M., Triebold, K. J., Koller, B., & Bloom, B. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12013 · Cited by 792
New aspects of natural-killer-cell surveillance and therapy of cancer
Smyth, M. J., Hayakawa, Y., Takeda, K., & Yagita, H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc928 · Cited by 752
Activation, coactivation, and costimulation of resting human natural killer cells
Bryceson, Y. T., March, M. E., Ljunggren, H., & Long, E. O. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00457.x · Cited by 650
The Role of the NKG2D Immunoreceptor in Immune Cell Activation and Natural Killing
Jamieson, A. M., Diefenbach, A., McMahon, C. W., Xiong, N., Carlyle, J. R., & Raulet, D. H. (2002) · Immunity · doi:10.1016/s1074-7613(02)00333-3 · Cited by 647
Self-citationHLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells
Gornalusse, G. G., Hirata, R. K., Funk, S. E., Riolobos, L., Lopes, V. S., Manske, G., Prunkard, D., Colunga, A. G., Hanafi, L.-A., Clegg, D. O., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3860 · Cited by 639
Self-tolerance of natural killer cells
Raulet, D. H., & Vance, R. E. (2006) · Nature Reviews Immunology · doi:10.1038/nri1863 · Cited by 608
Self-citationCD1d1 Mutant Mice Are Deficient in Natural T Cells That PromptlyProduce IL-4
Mendiratta, S. K., Martin, W. D., Hong, S., Boesteanu, A., Joyce, S., & Van Kaer, L. (1997) · Immunity · doi:10.1016/s1074-7613(00)80290-3 · Cited by 595
Fernandez, N. C., Treiner, E., Vance, R. E., Jamieson, A. M., Lemieux, S., & Raulet, D. H. (2005) · Blood · doi:10.1182/blood-2004-08-3156 · Cited by 588
Self-citationRoles of natural killer cells in immunity to cancer, and applications to immunotherapy
Wolf, N. K., Kissiov, D. U., & Raulet, D. H. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00732-1 · Cited by 577
Self-citationp46, a Novel Natural Killer Cell–specific Surface Molecule That Mediates Cell Activation
Sivori, S., Vitale, M., Morelli, L., Sanseverino, L., Augugliaro, R., Bottino, C., Moretta, L., & Moretta, A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.7.1129 · Cited by 554
Regulation of the Natural Killer Cell Receptor Repertoire
Raulet, D. H., Vance, R. E., & McMahon, C. W. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.291 · Cited by 521
Self-citationHuman natural killer cell development
Freud, A. G., & Caligiuri, M. A. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00451.x · Cited by 497
Developmental pathways that generate natural-killer-cell diversity in mice and humans
Huntington, N. D., Vosshenrich, C. A. J., & Di Santo, J. P. (2007) · Nature Reviews Immunology · doi:10.1038/nri2154 · Cited by 461
Yokoyama, W. M., & Seaman, W. E. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.003145 · Cited by 461
Diefenbach, A., Tomasello, E., Lucas, M., Jamieson, A. M., Hsia, J. K., Vivier, E., & Raulet, D. H. (2002) · Nature Immunology · doi:10.1038/ni858 · Cited by 452
Self-citationHsu, K. C., Chida, S., Geraghty, D. E., & Dupont, B. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.19004.x · Cited by 443
Natural Killer Cell Education and Tolerance
Orr, M. T., & Lanier, L. L. (2010) · Cell · doi:10.1016/j.cell.2010.08.031 · Cited by 441
Programming CAR-T cells to kill cancer
Labanieh, L., Majzner, R. G., & Mackall, C. L. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0235-9 · Cited by 431
Natural killer cell biology: An update and future directions
Campbell, K. S., & Hasegawa, J. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.07.006 · Cited by 416
Interplay of natural killer cells and their receptors with the adaptive immune response
Raulet, D. H. (2004) · Nature Immunology · doi:10.1038/ni1114 · Cited by 413
Self-citationNegative signaling by inhibitory receptors: the NK cell paradigm
Long, E. O. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00660.x · Cited by 370
The Natural Cytotoxicity Receptors in Health and Disease
Barrow, A. D., Martin, C. J., & Colonna, M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00909 · Cited by 370
The Yin and Yang of HLA and KIR in human disease
Kulkarni, S., Martin, M. P., & Carrington, M. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2008.06.003 · Cited by 363
Fas-mediated cytotoxicity by freshly isolated natural killer cells.
Arase, H., Arase, N., & Saito, T. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.3.1235 · Cited by 362
Development of human T and natural killer cells
Spits, H., Lanier, L., & Phillips, J. (1995) · Blood · doi:10.1182/blood.v85.10.2654.bloodjournal85102654 · Cited by 362
The Ets-1 Transcription Factor Is Required for the Development of Natural Killer Cells in Mice
Barton, K., Muthusamy, N., Fischer, C., Ting, C.-N., Walunas, T. L., Lanier, L. L., & Leiden, J. M. (1998) · Immunity · doi:10.1016/s1074-7613(00)80638-x · Cited by 359
Moretta, A., Biassoni, R., Bottino, C., Pende, D., Vitale, M., Poggi, A., Mingari, M. C., & Moretta, L. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb00943.x · Cited by 350
Wagtmann, N., Rajagopalan, S., Winter, C. C., Peruui, M., & Long, E. O. (1995) · Immunity · doi:10.1016/1074-7613(95)90069-1 · Cited by 335
Susceptibility of β2-microglobulin-deficient mice to Trypanosoma cruzi infection
Tarleton, R. L., Koller, B. H., Latour, A., & Postan, M. (1992) · Nature · doi:10.1038/356338a0 · Cited by 330
Natural killer cells and cancer
Brittenden, J., Heys, S. D., Ross, J., & Eremin, O. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960401)77:7<1226::aid-cncr2>3.0.co;2-g · Cited by 319
Yokoyama, W. M. (1995) · Current Opinion in Immunology · doi:10.1016/0952-7915(95)80036-0 · Cited by 299
Joncker, N. T., Fernandez, N. C., Treiner, E., Vivier, E., & Raulet, D. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803900 · Cited by 291
Self-citationNK cell education: not an on-off switch but a tunable rheostat
Brodin, P., Kärre, K., & Höglund, P. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.01.006 · Cited by 288
Unifying concepts of MHC-dependent natural killer cell education
Elliott, J. M., & Yokoyama, W. M. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.06.001 · Cited by 279
Brodin, P., Lakshmikanth, T., Johansson, S., Kärre, K., & Höglund, P. (2009) · Blood · doi:10.1182/blood-2008-05-156836 · Cited by 279
Sousa, A. O., Mazzaccaro, R. J., Russell, R. G., Lee, F. K., Turner, O. C., Hong, S., Van Kaer, L., & Bloom, B. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4204 · Cited by 275
Höglund, P., Ohlén, C., Carbone, E., Franksson, L., Ljunggren, H. G., Latour, A., Koller, B., & Kärre, K. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.22.10332 · Cited by 271
Iizuka, K., Naidenko, O. V., Plougastel, B. F. M., Fremont, D. H., & Yokoyama, W. M. (2003) · Nature Immunology · doi:10.1038/ni954 · Cited by 270
Innate Immune Surveillance of Spontaneous B Cell Lymphomas by Natural Killer Cells and γδ T Cells
Street, S. E. A., Hayakawa, Y., Zhan, Y., Lew, A. M., MacGregor, D., Jamieson, A. M., Diefenbach, A., Yagita, H., Godfrey, D. I., & Smyth, M. J. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031981 · Cited by 264
NKG2A Complexed with CD94 Defines a Novel Inhibitory Natural Killer Cell Receptor
Brooks, A. G., Posch, P. E., Scorzelli, C. J., Borrego, F., & Coligan, J. E. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.4.795 · Cited by 262
Mice lacking major histocompatibility complex class I and class II molecules.
Grusby, M. J., Auchincloss, H., Lee, R., Johnson, R. S., Spencer, J. P., Zijlstra, M., Jaenisch, R., Papaioannou, V. E., & Glimcher, L. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.3913 · Cited by 260
Self-citationLicensing of natural killer cells by self‐major histocompatibility complex class I
Yokoyama, W. M., & Kim, S. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00458.x · Cited by 259
Ly49 receptors: innate and adaptive immune paradigms
Rahim, M. M. A., Tu, M. M., Mahmoud, A. B., Wight, A., Abou-Samra, E., Lima, P. D. A., & Makrigiannis, A. P. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00145 · Cited by 97
Genetic Engineering of Immune Evasive Stem Cell-Derived Islets
Sackett, S. D., Kaplan, S. J., Mitchell, S. A., Brown, M. E., Burrack, A. L., Grey, S., Huangfu, D., & Odorico, J. (2022) · Transplant International · doi:10.3389/ti.2022.10817 · Cited by 32
Inhibition of antigen presentation during AAV gene therapy using virus peptides
Shao, W., Chen, X., Samulski, R. J., Hirsch, M. L., & Li, C. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddx427 · Cited by 17
Metadata
- Authors
- Liao, N.-S., Bix, M., Zijlstra, M., Jaenisch, R., & Raulet, D.
- Venue
- Science
- Published
- 1991-07-12
- Volume
- 253
- Issue
- 5016
- Pages
- 199-202
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2054726996
- Cited by
- 490
- References
- 25
- FWCI
- 9.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.